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TECHNICAL NOTE
Transcriptional activation of a hybrid promoter composed of
cytomegalovirus enhancer and -actin/-g1obin gene in
glomerular epithelial cells in vivo
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TosHilu MORIYAMA, ATSUSHI YAMAUCHI, MASARU HoRlo, NA0HIK0 UEDA, MASARU OKABE,
and ENYU IMA!
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Transcriptional activation of a hybrid promoter composed of cytomeg-
alovirus enhancer and l3-actin/-gobin gene in glomerular epithelial cells
in viva. The aim of this study was to seek a promoter, transactivated
selectively in renal cells in vivo by using transgenic (tg) mouse technology.
We generated tvo kinds of tg mouse lines carrying a green fluorescence
protein (GFP) eDNA driven either by cytomegalovirus enhancer and
13-actin/13-globin promoter (CX-GFP) or by elongation factor 1 promoter(EF-GFP), and investigated the expression of GFP in the kidney. Micro-
scopic examination of the renal tissues in CX-GFP-tg mice revealed that
GFP was expressed only in glomeruli, mainly epithelial cells, but not in
tubules, arteries and interstitium. Moreover, in situ hybridization demon-
strated that GFP mRNA expression was localized in the glomerular cells.
In contrast, GFP was not detectable in the kidney in any of the lines of
EF-GFP-tg mouse. To exclude the possible involvement of the GFP
eDNA as an enhancer, we constructed tg mice carrying the CX promoter
driving a human CD4 eDNA. It was confirmed that the expression
patterns of human CD4 in the kidney were quite similar to those of GFP
in the kidney of CX-GFP-tg mice. These results strongly suggest that CX
promoter could be transactivated in glomerular epithelial cells in vivo.
Intentional expression of a specific molecule in a living animal
by means of gene transduction would provide insight into the
physiological and pathophysiological role of the molecule. In this
context, numerous transgenic (tg) mice and knockout mice have
been developed. However, the systemic effect of the molecule is
inevitable in tg mice carrying an uninducible promoter, since the
molecule is overexpressed in an uncontrolled fashion from the
fetal stage. Therefore, the creation of a cell-specific and inducible
promoter, the "molecular switch" in a living animal, would be
expected to be a feasible tool for studying the molecular function
in vivo. However, an ideal promoter has never been found to allow
specific expression in a particular cell population in the kidney to
date.
Green fluorescence protein (GFP) in Aequorea victoria ab-
sorbs blue light and emits green fluorescence. This protein has
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been used as a reporter gene in molecular biology since it can be
detected immediately without any preliminary treatment [1—3].
GFP, in particular, possesses the merit that we can observe its
green fluorescence macroscopically as well as microscopically only
by exposure to ultraviolet (UV) light. Though the detection of
green fluorescence emitted by GFP under UV light is not so
sensitive, the visible illumination indicates that GFP is highly
transcribed in green fluorescence-positive cells.
We already reported that tg mice, which harbored a GFP
eDNA driven by a hybrid promoter composed of cytomegalovirus
(CMV) enhancer and J3-actin/f3-globin promoter (CX promoter),
expressed GFP in skeletal muscle, heart, pancreas and kidney [2].
In the present study, we constructed two kinds of tg mouse lines
carrying a GFP cDNA driven by either CX promoter or elonga-
tion factor la promoter (EF-la promoter), and investigated the
expression of GFP in the kidney. In order to identif' the cells in
which GFP is specifically transactivated by the CX promoter,
immunohistochemistry and in situ hybridization were performed.
We report here that CX promoter was able to induce a selective
and strong expression in glomerular epithelial cells in tg mice.
Methods
GFP transgenic mice
Construction of the transgene and production of the tg mice
was described in our previous paper [2]. Briefly, a GFP cDNA
(gift of Drs. Prasher and Chalfie) [1] was ligated to /3-actin/13-
globin promoter and CMV enhancer (pCX-GFP) [4]. Thirty lines
of tg mice were generated by injecting the SalIIBamHI DNA
fragment of pCX-GFP (referred to as CX-GFP-tg mice). Also, a
GFP cDNA was ligated to EF-la promoter (pEF-GFP) [5]. Three
lines of tg mice were generated by injecting the HindIIIIEcoRI
DNA fragment of pEF-GFP (referred to as EF-GFP-tg mice).
Human CD4 cDNA was excised from pSP65. T4.8 (gift of Dr.
Littman) [6] by EcoRI digestion and inserted into the pCAGGS
(pCX-hCD4). Five lines of tg mice were also generated by
injecting the SalIIHindIII DNA fragment of pCX-hCD4 (referred
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Fig. 1. Intrarenal expression of GFP and hCD4 in the transgenic mice
(X500). Representative fluorescence photomicrographs of the kidney in
the transgenic mice carrying GFP driven by either CX promoter (A;
CX-GFP-tg mice) or EF-ln promoter (B; EF-GFP-tg mice). In the kidney
of tg-CX-GFP mice, only glomeruli were illuminated in green, but tubules,
arteries and interstitium were not. In contrast, GFP illumination was not
observed in the kidney of EF-GFP-tg mice. In the transgenic mice carrying
the CX promoter driving human CD4 instead of a GFP eDNA, human
CD4 was also localized in glomeruli, mainly epithelial cells with quite
similar patterns of GFP expression in tg-CX-GFP mice (C).
Histological detection of GFP
For simple and quick detection of GFP, the mice were deeply
anesthetized and various organs were exposed under UV light
using a common transilluminator (Spectroline; TC-312A). When
transgene was present, organs expressing GFP could be easily
visualized macroscopically by the emission of green fluorescence.
Fig. 2. (top panels) Localization of GFP expression in the glomerulus assessed
by laminin labeling and HE staining (X500). A. Immunofluorescence staining
of laminin, a specific marker of GBM, demonstrated that most of the
GFP-positive cells (green) were present at the sites just outside of GBM
(yellow), indicating that they were glomerutar epithelial cells. B. This HE
staining shows the cells expressing GFP in the same section (arrows). It is
evident that most of the GFP-positive cells were glomerular epithelial cells.
Fig. 3. (bottom panel) The expression of GFP mRNA in the kidney of
CX-GFP-tg mice (X300). In situ hybridization was performed to determine
the cells synthesizing GFP de novo. In the kidney of CX-GFP-tg mice, the
hybridization signal was predominantly present in glomerular cells, presum-
ably epithelial cells and at a much lower level in tubules and interstitium.
Mouse kidneys, after perfused fixation with 4% paraformalde-
hyde (PFA) solution, were placed in 4% PFA solution for two
hours and subsequently in 30% sucrose solution overnight.
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Cryosections (4 m) mounted on glass slides were observed under
a Nikon fluorescent microscope equipped with filters DM510
(EX420 to 490 and BT520), which were the same filters used for
the detection of fluoresceinisothiocyanate (FITC).
To examine the cellular localization of GFP expression, the
sequential sections were stained with an antibody to laminin, a
specific marker of glomerular basement membrane (GBM). The
sections were incubated with a rabbit polyclonal IgG anti-mouse
laminin antibody diluted 1:50 (Becton Dickinson Labware Inc.,
MA, USA), followed by rhodamine-conjugated anti-rabbit IgG
(Chemicon Int., Inc., CA, USA). Thus, GFP positive cells and
GBM were revealed by green and red fluorescence, respectively.
The preparations were examined under a fluorescent microscope
equipped with filters for GFP or rhodamine. The green fluores-
cence of GFP and the red fluorescence of rhodamine were taken
by photomicrograph on the same film by double exposure.
The same sections were then stained with hematoxylin and
eosin (HE). We took light photomicrographs of the same glomer-
uli again in order to allow morphological identification of the
GFP-positive cells.
Histological detection of human CD4
Mouse kidneys after perfusion with 0.01 M phosphate buffered
saline (PBS) were placed in 30% sucrose solution overnight.
Cryosections (6 .Lm) were incubated with FITC-conjugated anti-
human CD4 monoclonal antibody H61 (gift of Dr. Yoshie) [21 for
one hour and washed with 0.01 M PBS.
RNA probes and in situ hybridization
To identify the cells synthesizing GFP de novo, in situ hybrid-
ization was performed. A GFP cDNA was inserted into the EcoRI
site of the pBluescript II SKt To make 35S-labeled sense and
antisense cRNA probes for GFP, in vitro transcription was
performed using T3 and T7 RNA polymerase, respectively, after
linearizing by cutting with AccI. The procedures for in situ
hybridization were described in our previous paper [7].
Results
Expression of GFP in transgenic mice
To identify the tissue- or cell-specific activity of a particular
promoter in tg mice, we employed GFP as a reporter protein
because of its quick and simple detection procedure. GFP expres-
sion was examined macroscopically in 30 lines of CX-GFP-tg mice
and 3 lines of EF-GFP-tg mice. All lines of CX-GFP-tg showed
strong expression of GFP in skeletal muscle, heart and pancreas,
although the expression could not be detected macroscopically in
liver, aorta and intestine. The illumination of GFP was not
detected on the surface of the kidney, however, illuminated spots
could be seen on the section. In contrast, no organs were
illuminated in any of the lines of EF-GFP-tg mouse (data not
shown).
Cellular localization of GFP expression in the glomerulus
Next, we examined the intrarenal microscopic expression of
GFP in 5 out of 30 lines of CX-GFP-tg mice and 3 lines of
EF-GFP-tg mice. Green fluorescence was observed in the glomer-
uli, but not in the tubules, arteries and interstitium on the kidney
section of CX-GFP-tg mice (Fig. IA). On the sections of other
organs including liver, intestine and aorta, illuminated cells were
not detected as far as we carefully observed. In EF-GFP-tg mice,
green fluorescence was not detected microscopically in any of the
organ including kidney (Fig. 1B). Since a GFP cDNA may include
an element to allow expression limited to glomerular epithelial
cells, we constructed 5 lines of tg mice carrying the CX promoter
driving human CD4 instead of a GFP cDNA. It was confirmed
that the expression patterns of human CD4 among organs were
quite similar to those of GFP in CX-GFP-tg mice. In the kidney,
the expression of human CD4 was also localized in glomeruli,
mainly epithelial cells (Fig. 1C).
Then, we identified the GFP-positive cells in the glomerulus by
means of immunofluorescence staining of laminin, a specific
marker of GBM. It was revealed that most of the GFP-positive
cells (green) were present at the sites just outside of GBM
(yellow), indicating that GFP was highly expressed in glomerular
epithelial cells (Fig. 2A). Most of the GFP-positive cells could be
identified as epithelial cells on the same section stained with HE
afterwards (Fig. 2B). Similarly, the expression of human CD4 in
CX-hCD4-tg mice seemed to be mainly limited to epithelial cells.
In situ hybridization of the GFP probe
GFP seemed to exist in glomerular epithelial cells, however, it
still remained unclear whether GFP was originally transcribed in
glomerular epithelial cells. Therefore, we sought to determine the
cells synthesizing GFP de novo by using an in situ hybridization
technique. It was revealed that GFP mRNA in CX-GFP-tg mice
was highly expressed in the glomerular cells and was at a much
lower level in the tubules and interstitium (Fig. 3). Hybridization
signals with the control sense probe were not detected in the
kidney. These results strongly suggested that GFP was highly
transcribed in glomerular cells, presumably epithelial cells. The
expression of GFP mRNA was not detected in the kidney of
EF-GFP-tg mice (data not shown).
Discussion
In the present study, we demonstrated that CX promoter
activated the transcription of GFP selectively in glomerular
epithelial cells as well as in skeletal muscle, pancreas and heart.
This is the first report that a promoter was selectively activated in
the glomerular epithelial cells in vivo. The CX promoter was
originally developed as an ubiquitous and strong promoter,
pCAGGS [4] by utilizing the character of cytoplasmic J3-actin
promoter that is highly active in a wide range of cell types as a
house keeping gene. Indeed, pCAGGS, was used for a transient
transfection in a variety of cells including the kidney fibroblast cell
line, mesangial cells and hematopoetic cells. We found that the
transcriptional activity of the CX promoter was limited specifically
to the tissues that included the glomerular epithelial cells in the tg
mice, while the expression of the CX promoter was generally
considered to be strong in transient transfection in cultured cells.
It is still unclear why the difference in transcriptional activation
was observed between in vivo glomeruli of tg mice and in vitro
cultured renal cells; however, it was reported that extracellular
matrix (ECM)-cell and cell-cell interactions are essential for the
regulation of many genes in differentiated cells and that several
expression vectors which work well in tissue culture cells are
sometimes inactive in vivo and vice versa [81. Furthermore, the
CMV enhancer was reported to be more active in the epithelial
cells in contact with ECM [8]. Another possibility is that CX
promoter may lose the essential cis-elements for the transactiva-
tion of native -actin genes in other cells. These possibilities may,
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in part, show that CX promoter provided the selective expression
in the glomerular epithelial cells in tg mice.
The expression of transgene has often been reported to be
different among tg animals [91. This may be partly due to the copy
number and the site of integration into the host genome. How-
ever, this glomerular cell-specific activation by CX promoter is not
due to the copy number or integration site, since no significant
difference was observed in the expression of the transgene among
30 lines of tg mice whose genomes had different copy numbers
and integration sites of the transgene.
Another possibility is that a GFP cDNA may include an
element to allow the selective expression in glomerular epithelial
cells. However, in the kidneys of tg mice carrying the CX
promoter driving human CD4 instead of a GFP cDNA, human
CD4 expression was also localized in glomeruli with quite similar
patterns of GFP expression in tg-CX-GFP mice. Hence, this is not
the case where an element of the reporter gene acts as a
tissue-specific enhancer for the glomerular epithelial cells.
The CX promoter used in this study is composed of the CMV
enhancer, a fragment of chicken J3-actin gene (—276 to + 969 bp),
including a 5 '-flanking region, the first exon, the first intron and a
part of the second exon, and a fragment of rabbit -globin gene,
including a part of the second and the third exon. This CX
promoter contains five putative spi binding elements within 220
bp upstream of the CAP site, five putative basic helix-loop-helix
(bHLH) transcription factor binding sites (CANNTG), three
NF-1 elements (CCAAT) at positions —491, —222 and —91, three
CArG boxes (CCWWWWWWGG) at —599, —60 and +685, a
NFKB binding site at —482 and a TATA box at —29. The CArG
box, in particular, is reported to bind the serum responsive factor
[10], and this element is considered to play an important role in
the transactivation of gene components of the cytoskeleton,
including actins. In cytoplasmic -actin genes, the CArG box in
the first intron is reported to act as a principal enhancer [11].
There are several reports using tg mice harboring a -actin
promoter. Sands et al reported that 7 out of 10 lines tg mice
harboring a f3-galactosidase cDNA driven by a 13-actin promoter
(—433 to +61) expressed p-galactosidase in testis, but the rest of
the 3 lines expressed it in skeletal muscle and heart [121. The tg
mice harboring a chicken )3-actin promoter (—330 to +10) and a
3899 bp of fragment of homeobox gene, Hox-l.1, showed scat-
tered expression in brain, stomach, heart, lung, bladder, muscle
and vertebra columun [13]. Merlino et a! also generated the tg
mice harboring an epidermal growth factor (EGF) cDNA driven
by a /3-actin promoter (—339 to +1) [14]. The transgene was
sporadically expressed in various tissues including spleen, testis,
liver, brain and lung. The expression patterns of the transgene in
these reports are distinct from our results. The major cause of the
different expression among these tg animals is considered to be
the presence of the first intron and CMV enhancer. Very recently,
Marber et al also showed that the same CX promoter selectively
activated transgene 70-kDa heat stress protein (HSP-70) in heart
and skeletal muscle in tg mice, although they did not examine the
expression of HSP-70 in the kidney [15]. However, further studies
are required to examine whether glomerular epithelial cell-
specific enhancer localizes in this hybrid promoter.
EF-la promoter is considered to show a strong activity in
various murine tissues and has been utilized for a transient
transfection in vitro. Therefore, it was expected that EF-GFP-tg
mice would ubiquitously express the transgene. From our results,
the expression of GFP was not detected under UV light in any of
the lines of EF-GFP-tg mouse, although a slight expression of
GFP mRNA or its protein might be detectable by highly sensitive
analysis, such as reverse transcription-PCR or immunohistochem-
istry. It has been reported that EF-la promoter was utilized for
the generation of the salt sensitive hypertensive tg mouse strain
overexpressing Na-H exchanger [161. In this model, exogenous
Na -H exchanger was detected in renal tubule cells as well as
glomerular epithelial cells by sensitive immunohistochemistry.
These results may conflict with our results, however, a weak
expression of protein was not our goal. Our aim was to identify the
promoter which enables the expression of abundant protein
selectively in the kidney, as in the results obtained from the CX
promoter.
In conclusion, we developed new lines of tg mice carrying a CX
promoter by which selective expression of cDNA occurred in
glomerular epithelial cells. This CX promoter may be applicable
to the production of a new model mouse with selective glomerular
epithelial lesions. We further speculate that a glomerular epithe-
hal cell-specific enhancer element may be identified in the region
of this hybrid promoter.
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